Ind-Swift Laboratories

Ind-Swift Laboratories, established in 1995, is a prominent entity within the Pharmaceuticals and Healthcare sectors. The company specializes in the production and development of chemicals and add-ins crucial for pharmaceutical products. Operating from India, Ind-Swift Laboratories has built a reputation for its contributions to the pharmaceutical supply chain, focusing on essential chemical compounds and specialized additives that enhance drug formulations and manufacturing processes. Its strategic focus on these core areas positions it as a key player in the industry.

With a substantial operational footprint, Ind-Swift Laboratories employs between 1,000 and 5,000 professionals, underscoring its significant scale. The company manages operations across 5 locations, indicating a broad reach within its market. Its product portfolio includes formulations, APIs (Active Pharmaceutical Ingredients), and synthetic chemistry services, catering to diverse client needs. The company generates an annual revenue of $118.9M, reflecting its market performance and business volume. For insights into the people driving this enterprise, one can explore Meet Ind-Swift Laboratories's team.

Ind-Swift Laboratories serves both B2B and B2C markets, demonstrating a versatile business model. Its presence in India and the broader Asia Pacific region highlights its geographic focus and market penetration. The company's expertise in synthetic chemistry and laboratory services supports its role in advancing pharmaceutical development and production. While specific competitors are not detailed, its long-standing presence since 1995 suggests a well-established market position. The company's fiscal year concludes on March 31st, aligning with standard financial reporting practices.